These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7022875)

  • 1. Use of ATG for reversal of acute allograft rejection.
    Nowygrod R; Appel G; Hardy MA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):469-72. PubMed ID: 7022875
    [No Abstract]   [Full Text] [Related]  

  • 2. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of acute renal allograft rejection with adjunctive AG therapy.
    Filo RS; Smith EJ; Leapman SB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):482-90. PubMed ID: 7022879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antilymphoblast globulin in the treatment of renal allograft rejection.
    Howard RJ; Condie RM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):473-4. PubMed ID: 7022876
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical value of antilymphocyte antibodies.
    Cosimi AB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):462-8. PubMed ID: 7022874
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection episodes after kidney transplantation.
    Hamida FB; Barbouch S; Bardi R; Helal I; Kaaroud H; Fatma LB; Hedri H; Abderrahim E; Abdallah TB; Ayed K; Maiz HB; Kheder A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):370-4. PubMed ID: 19414936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
    Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):20-2. PubMed ID: 2964112
    [No Abstract]   [Full Text] [Related]  

  • 11. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early acute kidney allograft rejection in patients with triple-drug immunosuppressive treatment.
    Isoniemi H; Eklund B; Häyry P; Höckerstedt K; Korsbäck C; von Willebrand E; Ahonen J
    Transplant Proc; 1988 Jun; 20(3):447-8. PubMed ID: 3289182
    [No Abstract]   [Full Text] [Related]  

  • 13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of methylprednisolone on first renal allograft rejection.
    Ahonen J; Häyry P; von Willebrand E; Eklund B; Lindström BL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):328-31. PubMed ID: 7022846
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of renal allograft acute rejection with methylprednisolone: effect of fixed dose versus dose per body mass index.
    Douzdjian V; Rice JC; Gugliuzza KK; Fisch JC; Carson RW
    Clin Transplant; 1996 Jun; 10(3):310-5. PubMed ID: 8826672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of early diagnose and treatment of subclinical renal allograft rejection].
    Zeng JH; Yu LX; Luo HH; Wang XC; Wang X; Fang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):697-8. PubMed ID: 16762888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
    Schulz T; Papapostolou G; Schenker P; Kapischke M
    Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.
    Küchle CC; Thoenes GH; Langer KH; Schorlemmer HU; Bartlett RR; Schleyerbach R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1083-6. PubMed ID: 1989154
    [No Abstract]   [Full Text] [Related]  

  • 19. Antilymphoblast globulin for treatment of acute renal allograft rejection.
    Streem SB; Novick AC; Braun WE; Steinmuller DR
    Cleve Clin Q; 1982; 49(4):219-24. PubMed ID: 6762935
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithymocyte globulin as the primary treatment for renal allograft rejection.
    Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
    Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.